Day One Biopharmaceuticals Inc. (NASDAQ: DAWN) completed its acquisition of Mersana Therapeutics Inc. (NASDAQ: MRSN) on January 6, 2026, following ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE